documents: FDA-2013-D-1445-0013

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2013-D-1445-0013 FDA FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period Notice Extension of Comment Period 2014-04-09T04:00:00Z 2014 4 2014-04-09T04:00:00Z 2014-05-08T03:59:59Z 2014-05-09T01:02:01Z 2014-07898 0 0 09000064816ab265

Links from other tables